Eye care non-profit Orbis International and Hoya Vision Care have renewed a partnership that began in 2021.
Frontera Therapeutics has dosed its first patients in a gene therapy trial for the treatment of X-Linked retinitis pigmentosa.
A team of researchers has achieved ‘proof of concept’ for a contact lens prototype, specifically designed to prevent contact lens-induced dry eye (CLIDE).
Australia will seek to help restore health gains lost in Pacific and Southeast Asian nations through the pandemic, with the announcement of a five
DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.
